{{Drugbox
| verifiedrevid = 447927638
| IUPAC_name = 17-(2-Phenylethyl)morphinan-3-ol
| image = Phenomorphan.svg
| width = 230px

<!--Clinical data-->
| tradename =  
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B            / C / D / X -->
| pregnancy_category =  
| legal_AU = S9
| legal_CA = Schedule I
| legal_UK = Class A
| legal_US = Schedule I
| legal_DE = Anlage I
| routes_of_administration =

<!--Pharmacokinetic data-->
| bioavailability =  
| protein_bound =  
| metabolism =  
| elimination_half-life =  
| excretion =

<!--Identifiers-->
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 468-07-5
| ATC_prefix = none
| ATC_suffix =  
| PubChem = 5362458
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank =  
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 16735962
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 26HXE4B73P

<!--Chemical data-->
| C=24 | H=29 | N=1 | O=1 
| molecular_weight = 347.493 g/mol
| smiles = Oc3ccc4C[C@H]1N(CC[C@@]2(CCCC[C@@H]12)c4c3)CCc5ccccc5
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C24H29NO/c26-20-10-9-19-16-23-21-8-4-5-12-24(21,22(19)17-20)13-15-25(23)14-11-18-6-2-1-3-7-18/h1-3,6-7,9-10,17,21,23,26H,4-5,8,11-16H2/t21-,23+,24+/m0/s1
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = CFBQYWXPZVQQTN-QPTUXGOLSA-N
| synonyms = <small>(-)-3-hydroxy- ''N''- (2-phenylethyl) morphinan</small>
}}

'''Phenomorphan'''<ref>{{ cite patent
| country = US
| number = 2885401
| status = patent
| title = Process for making morphinan derivatives and products available thereby
| pubdate = 1956-03-22
| gdate = 1959-05-05
| inventor = Andre Grussner, Joseph Hellerbach, Otto Schnider
}}</ref> is an [[opioid]] [[analgesic]]. It is not currently used in medicine, but has similar side-effects to other opiates, which include [[itching]], [[nausea]] and [[respiratory depression]].

Phenomorphan is a highly potent drug due to the N-phenethyl group, which boosts affinity to the [[Î¼-opioid receptor]], and so phenomorphan is around 10x more potent than [[levorphanol]], which is itself 6-8x the potency of [[morphine]]. Other analogues where the N-(2-phenylethyl) group has been replaced by other aromatic rings.<ref>{{ cite patent
| country = US
| number = 2970147
| status = patent
| title = 3-hydroxy-N-(heterocyclic-ethyl)-morphinans
| pubdate = 1958-11-26
| gdate = 1961-01-31
| inventor = Andre Grussner, Joseph Hellerbach, Otto Schnider
}}</ref> are even more potent, with the N-(2-(2-[[furan|furyl]])ethyl) and the N-(2-(2-[[thiophene|thienyl]])ethyl) analogues being 60x and 45x stronger than levorphanol, respectively.<ref>{{cite book |author1=Hellerbach J. |author2=Schnider O |author3=Besendorf H |author4=Pellmont B | series= International series of monographs on organic chemistry | title = Synthetic Analgesics: Part IIA. Morphinans | publisher = Pergamon Press | year = 1966 | url=https://www.scribd.com/doc/39966259/Synthetic-Analgesics-1966-Part-IIA-Morphinans }}</ref>

==See also==
* [[14-Cinnamoyloxycodeinone]]
* [[14-Phenylpropoxymetopon]]
* [[7-PET]]
* [[N-Phenethylnormorphine]]
* [[N-Phenethylnordesomorphine]]
* [[N-Phenethyl-14-ethoxymetopon]]
* [[RAM-378]]
* [[Ro4-1539]]

==References==
{{Reflist|2}}

{{Opioidergics}}

[[Category:Synthetic opioids]]
[[Category:Morphinans]]
[[Category:Phenols]]
[[Category:Mu-opioid agonists]]


{{pharm-stub}}